Navigation Links
Exhaust From Railroad Diesel Linked to Lung Ailments
Date:11/25/2008

Study measured respiratory history of 30,000 RR workers since 1959

TUESDAY, Nov. 25 (HealthDay News) -- Long-term exposure to diesel exhaust fumes may increase the risk of chronic obstructive pulmonary disease (COPD), which includes lung conditions such as bronchitis and emphysema.

U.S. researchers studied the job and health records of more than 30,000 railway workers and found that those who worked on diesel trains (engineers, brakemen, conductors) were more likely to die of COPD than those who worked in ticketing, signaling, maintenance, or administration.

The health records used were from the U.S. Railroad Retirement Board, dating back to 1959.

Diesel exhaust includes fine particulate matter and combustion gases that can be inhaled deep into the lungs. Previous studies have made a link between the organic compounds in diesel exhaust and allergy, airway inflammation, and changes in airway functioning.

The COPD risk for workers directly exposed to diesel exhaust increased by 2.5 percent per year of employment. That risk fell slightly after adjusting for smoking, a known risk factor for COPD, said lead researcher Dr. Jaime Hart, of Brigham and Women's Hospital and Harvard Medical School in Boston, according to a news release from the two institutions.

The study was published in the journal Occupational and Environmental Medicine.

More information

The American Academy of Family Physicians has more about COPD.



-- Robert Preidt



SOURCE: BMJ specialist journals, news release, Nov. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Summer is for Sleeping? Exhausted Americans Challenged to Sleep-in on Longest Day of the Year
2. Traffic exhaust can cause asthma, allergies and impaired respiratory function in children
3. Why exertion leads to exhaustion
4. Diesel Exhaust Increases Clot Formation
5. Diesel exhaust associated with higher heart attack, stroke risk in men
6. Diesel exhaust may increase risk in patients with heart disease
7. Safety Threat to Rochester Still Remains Despite Approval Of Canadian Pacifics Railroad Acquisition Of DM&E
8. Rochester Coalition and Mayo Clinic Challenge Railroads Contention That Hazmat Rail Shipments Pose no Risk
9. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
10. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad
11. U.S. Reps. Oberstar and Walz Discuss DM&E Railroad Expansion With Rochester, Minn. Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Exhaust From Railroad Diesel Linked to Lung Ailments
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016  EIP ... it has obtained proof-of-mechanism for neflamapimod (previously code ... completed Phase 2a clinical trials that demonstrated significant ... Study 302 (12-week treatment) and Study 303 (6-week ... Clinical Trials in Alzheimer,s Disease (CTAD) scientific conference ...
(Date:12/8/2016)... , Dec. 8, 2016 A Small ... the National Institutes of Health (NIH) to ... University.  The grant will seek to ... head device, which utilizes electromagnetic waves to treat Alzheimer,s ... this novel technology to possibly treat other neurologic disorders ...
Breaking Medicine Technology: